PhaseV, a leader in AI/ML for clinical development, today announced the launch of its new Enrollment Lab solution at the 17th ...
A novel collaboration may establish a framework to help researchers overcome regulatory barriers they often face when ...
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the ...
The FDA has requested new human factors and pharmacology studies for Anaphylm sublingual film following deficiencies in original NDA packaging data.
AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.
The Alliance of Community Health Plans (ACHP) announced today a funding award aimed at prioritizing the perspectives of patients with chronic diseases and their families in clinical research, ...
How much should psychedelics researchers disclose about their personal use of psilocybin, ketamine, and other drugs?
Discusses FDA Complete Response Letter and Next Steps for Anaphylm Epinephrine Sublingual Film February 2, 2026 8:00 ...
@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...
A major new clinical trial will compare two dietary approaches, nutritional ketosis diet and the NHS EatWell guidelines in patients with bipolar depression.
ISTANBUL, TR - December 19, 2025 - PRESSADVANTAGE - Maltepe Dental Clinic, an Istanbul-based dental practice with 22 ...
CYCN READ THE FULL CYCN RESEARCH REPORT Initiating Coverage We are initiating coverage of Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) with a valuation of $8.00. Cyclerion is a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results